Across the recent three months, 14 analysts have shared their insights on Axsome Therapeutics (NASDAQ:AXSM), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 9 | 4 | 1 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 5 | 2 | 0 | 0 | 0 |
2M Ago | 1 | 1 | 1 | 0 | 0 |
3M Ago | 2 | 1 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Axsome Therapeutics, presenting an average target of $132.14, a high estimate of $190.00, and a low estimate of $95.00. A decline of 0.18% from the prior average price target is evident in the current average.
Exploring Analyst Ratings: An In...
ログインすると全部閲覧できます。
ログイン